Literature DB >> 18316631

Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis.

Marnie J Wood1, Lawrie W Powell, Grant A Ramm.   

Abstract

Hereditary hemochromatosis is a genetic disorder of iron metabolism leading to inappropriate iron absorption and iron loading in various organs especially the liver. Despite the genetic mutation being relatively common in those of Anglo Celtic descent, cirrhosis of the liver occurs in only a small proportion of affected individuals. The risk of hepatic fibrosis and cirrhosis relates to the degree of iron loading with threshold hepatic iron concentrations being identified from population studies. However, other environmental and possibly genetic factors appear to modify this risk. Excess alcohol consumption appears to be one of the most important cofactors with steatosis and coexistent viral infection also implicated. Genetic polymorphisms in genes associated with fibrogenesis, antioxidant activity, and inflammation have been investigated in several different forms of chronic liver disease. The variability in the expression of these genes that predispose patients with hemochromatosis to increased risk of severe liver disease is the subject of ongoing investigations. Clearly the progression of iron loading to cirrhosis marks a crucial stage in the natural history of a patient's disease and therefore therapy and prognosis. This review explores recent developments in knowledge of environmental and genetic modifiers of this process.

Entities:  

Mesh:

Year:  2008        PMID: 18316631     DOI: 10.1182/blood-2007-11-122374

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Non-alcoholic fatty liver disease: is iron relevant?

Authors:  Julia O'Brien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2011-08-12       Impact factor: 6.047

2.  Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated with iron overload and progressive liver disease.

Authors:  Benedikt Schaefer; David Haschka; Armin Finkenstedt; Britt-Sabina Petersen; Igor Theurl; Benjamin Henninger; Andreas R Janecke; Chia-Yu Wang; Herbert Y Lin; Lothar Veits; Wolfgang Vogel; Günter Weiss; Andre Franke; Heinz Zoller
Journal:  Hum Mol Genet       Date:  2015-08-26       Impact factor: 6.150

3.  Effect of hereditary haemochromatosis genotypes and iron overload on other trace elements.

Authors:  Jeffrey M Beckett; Madeleine J Ball
Journal:  Eur J Nutr       Date:  2012-02-09       Impact factor: 5.614

Review 4.  Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease.

Authors:  Elena Canavesi; Carlo Alfieri; Serena Pelusi; Luca Valenti
Journal:  World J Nephrol       Date:  2012-12-06

5.  Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis.

Authors:  Marnie J Wood; Lawrie W Powell; Jeannette L Dixon; V Nathan Subramaniam; Grant A Ramm
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

6.  Themes in fibrosis and gastrointestinal inflammation.

Authors:  Claudio Fiocchi; P Kay Lund
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-17       Impact factor: 4.052

7.  Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.

Authors:  Luca Valenti; Paolo Maggioni; Alberto Piperno; Raffaela Rametta; Sara Pelucchi; Raffaella Mariani; Paola Dongiovanni; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

Review 8.  Endocrine dysfunction in hereditary hemochromatosis.

Authors:  C Pelusi; D I Gasparini; N Bianchi; R Pasquali
Journal:  J Endocrinol Invest       Date:  2016-03-07       Impact factor: 4.256

Review 9.  New approaches for fibrosis regression in alcoholic cirrhosis.

Authors:  Wajahat Mehal; Uyen To
Journal:  Hepatol Int       Date:  2016-07-26       Impact factor: 6.047

10.  Paraoxonase-1 status in patients with hereditary hemochromatosis.

Authors:  Nicola Martinelli; Anabel García-Heredia; Helena Roca; Núria Aranda; Victoria Arija; Bharti Mackness; Michael Mackness; Fabiana Busti; Gerard Aragonès; Juan Pedro-Botet; Federica Pedica; Ivana Cataldo; Judit Marsillach; Jorge Joven; Domenico Girelli; Jordi Camps
Journal:  J Lipid Res       Date:  2013-03-06       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.